Inventor · disambiguated record
Patricia S. Campbell
Also filed as: CAMPBELL PATRICIA S
24 granted patents·2 pending applications·2,355 citations·filing 1981–2005
98Inventor score
Top patents by PatentIndex Score
26 records- 0199US4379454ADosage for coadministering drug and percutaneous absorption enhancerALZA CORP·Filed 1981·Granted Apr 12, 1983·586 cites·16 claims
- 0298US4704282ATransdermal therapeutic system having improved delivery characteristicsALZA CORP·Filed 1984·Granted Nov 3, 1987·181 cites·43 claims
- 0396US4816258ATransdermal contraceptive formulationsALZA CORP·Filed 1987·Granted Mar 28, 1989·188 cites·26 claims
- 0495US4908027ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1986·Granted Mar 13, 1990·174 cites·29 claims
- 0594US5342623ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1993·Granted Aug 30, 1994·144 cites·15 claims
- 0692US7011844B2Formulations for the administration of fluoxetineALZA CORP·Filed 2002·Granted Mar 14, 2006·29 cites·10 claims
- 0790US6512010B1Formulations for the administration of fluoxetineALZA CORP·Filed 1997·Granted Jan 28, 2003·76 cites·34 claims
- 0889US5512293AOral sustained release drug delivery deviceALZA CORP·Filed 1993·Granted Apr 30, 1996·129 cites·25 claims
- 0989US4832953AMethod for preventing the formation of a crystalline hydrate in a dispersion of a liquid in a monaqueous matrixALZA CORP·Filed 1987·Granted May 23, 1989·100 cites·24 claims
- 1086US5840327ATransdermal drug delivery device having enhanced adhesionALZA CORP·Filed 1996·Granted Nov 24, 1998·78 cites·12 claims
- 1186US5462745ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1994·Granted Oct 31, 1995·72 cites·10 claims
- 1285US4725439ATransdermal drug delivery deviceALZA CORP·Filed 1986·Granted Feb 16, 1988·68 cites·54 claims
- 1383US6007837ADrug delivery devices and process of manufactureALZA CORP·Filed 1999·Granted Dec 28, 1999·70 cites·16 claims
- 1483US5344656ASubsaturated transdermal therapeutic system having improved release characteristicsALZA CORP·Filed 1993·Granted Sep 6, 1994·62 cites·12 claims
- 1583US4867982ATransdermal drug delivery deviceALZA CORP·Filed 1988·Granted Sep 19, 1989·62 cites·39 claims
- 1679US6001390AFormulations for transdermal delivery of pergolideALZA CORP·Filed 1996·Granted Dec 14, 1999·41 cites·30 claims
- 1778US4460372APercutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancerALZA CORP·Filed 1983·Granted Jul 17, 1984·120 cites·11 claims
- 1863US6572879B1Formulations for transdermal delivery of pergolideALZA CORP·Filed 1995·Granted Jun 3, 2003·19 cites·47 claims
- 1962US2005186277A1Novel formulations for the administration of fluoxetineFiled 2005·Application pending·0 cites
- 2058US2004209909A1Novel formulations for transdermal delivery of pergolideYUM SU IL·Filed 2002·Application pending·0 cites
- 2155US5990179AComposition and method of enhancing electrotransport agent deliveryALZA CORP·Filed 1995·Granted Nov 23, 1999·59 cites·18 claims
- 2253US6324424B1Reduction of skin irritation during electrotransport deliveryALZA CORP·Filed 1998·Granted Nov 27, 2001·42 cites·23 claims
- 2353US5985316AComposition and method of enhancing electrotransport agent deliveryALZA CORP·Filed 1995·Granted Nov 16, 1999·14 cites·25 claims
- 2445US6174545B1Drug delivery devices and process of manufactureALZA CORP·Filed 1999·Granted Jan 16, 2001·9 cites·8 claims
- 2541US5693010AReduction of skin irritation during electrotransport deliveryALZA CORP·Filed 1996·Granted Dec 2, 1997·22 cites·22 claims
- 2634US5865792AReduction of skin irritation during electrotransport deliveryALZA CORP·Filed 1997·Granted Feb 2, 1999·10 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when Patricia S. Campbell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →